The Evolutionary Landscape of Treatment for BRAF(V600E) Mutant Metastatic Colorectal Cancer

SIMPLE SUMMARY: The BRAF(V600E) mutation accounts for 8–10% of metastatic colorectal cancer (mCRC) patients and it is an established prognostic factor. Median overall survival of this subset of patients is indeed so poor that it is similar to first line PFS of patients without this molecular alterat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Mauri, Gianluca, Bonazzina, Erica, Amatu, Alessio, Tosi, Federica, Bencardino, Katia, Gori, Viviana, Massihnia, Daniela, Cipani, Tiziana, Spina, Francesco, Ghezzi, Silvia, Siena, Salvatore, Sartore-Bianchi, Andrea
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7795863/
https://ncbi.nlm.nih.gov/pubmed/33406649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13010137
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars